SLC6A4 and ovarian cancer: A direct or indirect (5-HT mediated) effect of SSRIs on cancer cells appears likely, as in addition to their inhibitory action on the SERT, interaction of different SSRIs with alternate neurotransmitter receptors that are expressed on breast and ovarian cancer tissues and cell lines was described (reviewed in15–17)14,18–20.